基于机器学习的急性冠脉综合征后不良事件预测(PRAISE):汇总数据建模研究
本研究利用BleeMACS和RENAMI登记处19 826例成人ACS患者数据训练多种机器学习模型,预测出院后1年全因死亡、心肌梗死和大出血(BARC 3或5型),并在3444例外部验证队列中测试最佳模型PRAISE。PRAISE评分对全因死亡、心肌梗死和大出血均表现出良好的区分能力,可能有助于指导临床决策。
要点
- PRAISE评分预测1年全因死亡的外部验证AUC为0·92(95%CI 0·90-0·93)。
- 预测1年心肌梗死的外部验证AUC为0·81(95%CI 0·76-0·85)。
- 预测1年大出血的外部验证AUC为0·86(95%CI 0·82-0·89)。
核心结论
- 基于机器学习的PRAISE评分能准确区分ACS后1年全因死亡、心肌梗死和大出血,可能辅助临床决策。
研究设计与样本
- 在BleeMACS和RENAMI登记处19 826例成人ACS患者中训练多种机器学习模型(80%训练集,20%内部验证集),使用出院时常规评估的25个临床特征。
- 最佳模型PRAISE在3444例ACS患者的外部验证队列中测试,该队列来自一项随机对照试验和三项前瞻性登记处。
主要发现
- 1年全因死亡:内部验证AUC 0·82(95%CI 0·78-0·85),外部验证AUC 0·92(95%CI 0·90-0·93)。
- 1年心肌梗死:内部验证AUC 0·74(95%CI 0·70-0·78),外部验证AUC 0·81(95%CI 0·76-0·85)。
- 1年大出血(BARC 3或5型):内部验证AUC 0·70(95%CI 0·66-0·75),外部验证AUC 0·86(95%CI 0·82-0·89)。
关键数值与推荐
- 大出血定义为Bleeding Academic Research Consortium(BARC)3型或5型。
- 模型性能主要采用受试者工作特征曲线下面积(AUC)等学习指标评估。
临床怎么用
- PRAISE评分可用于ACS患者出院时风险评估,辅助识别1年全因死亡、心肌梗死和大出血高风险个体。
- 该工具可能帮助临床医生制定个体化患者管理策略,但需进一步验证其临床效用。
局限性
- 研究为建模研究,外部验证队列来自随机对照试验和前瞻性登记处,可能存在选择偏倚。
- 原文未报告模型的校准度、临床决策影响或前瞻性干预研究结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The accuracy of current prediction tools for ischaemic and bleeding events after an acute coronary syndrome (ACS) remains insufficient for individualised patient management strategies. We developed a machine learning-based risk stratification model to predict all-cause death, recurrent acute myocardial infarction, and major bleeding after ACS. METHODS: Different machine learning models for the prediction of 1-year post-discharge all-cause death, myocardial infarction, and major bleeding (defined as Bleeding Academic Research Consortium type 3 or 5) were trained on a cohort of 19 826 adult patients with ACS (split into a training cohort [80%] and internal validation cohort [20%]) from the BleeMACS and RENAMI registries, which included patients across several continents. 25 clinical features routinely assessed at discharge were used to inform the models. The best-performing model for each study outcome (the PRAISE score) was tested in an external validation cohort of 3444 patients with ACS pooled from a randomised controlled trial and three prospective registries. Model performance was assessed according to a range of learning metrics including area under the receiver operating characteristic curve (AUC). FINDINGS: The PRAISE score showed an AUC of 0·82 (95% CI 0·78-0·85) in the internal validation cohort and 0·92 (0·90-0·93) in the external validation cohort for 1-year all-cause death; an AUC of 0·74 (0·70-0·78) in the internal validation cohort and 0·81 (0·76-0·85) in the external validation cohort for 1-year myocardial infarction; and an AUC of 0·70 (0·66-0·75) in the internal validation cohort and 0·86 (0·82-0·89) in the external validation cohort for 1-year major bleeding. INTERPRETATION: A machine learning-based approach for the identification of predictors of events after an ACS is feasible and effective. The PRAISE score showed accurate discriminative capabilities for the prediction of all-cause death, myocardial infarction, and major bleeding, and might be useful to guide clinical decision making. FUNDING: None.
引用
- D'Ascenzo F, De Filippo O, Gallone G, et al. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets. Lancet. 2021. PMID: 33453782. doi:10.1016/S0140-6736(20)32519-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。